TLR2 down-regulates FcεRI and its transcription factor PU.1 in human Langerhans cells

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 5, 2013, Pages 621-628

  Herrmann, N ^a   Koch, S ^a   Leib, N ^a   Bedorf, J ^a   Wilms, H ^a   Schnautz, S ^a   Fimmers, R ^a   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

allergy; atopy; Fc RI; Langerhans cells; TLR2

Indexed keywords

CD34 ANTIGEN; CD83 ANTIGEN; FC RECEPTOR; HIGH AFFINITY IMMUNOGLOBULIN E RECEPTOR; LANGERIN; MESSENGER RNA; RNA; T6 ANTIGEN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ALPHA CHAIN; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIGENS, CD34; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; LANGERHANS CELLS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTORS, IGE; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84876669346     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12145     Document Type: Article

References (34)

1. Steinman RM,. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30: 1-22.
2. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, et al. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002; 168: 1704-1709. (Pubitemid 34135767)
3. Kapsenberg ML,. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3: 984-993. (Pubitemid 37521540)
4. Novak N, Koch S, Allam JP, Bieber T,. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol 2010; 125: 50-59.
5. Shklovskaya E, O'Sullivan BJ, Ng LG, Roediger B, Thomas R, Weninger W, et al. Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci USA 2011; 108: 18049-18054.
6. Romani N, Brunner PM, Stingl G,. Changing views of the role of Langerhans cells. J Invest Dermatol 2012; 132 (3 Pt 2): 872-881.
7. Wollenberg A, Kraft S, Hanau D, Bieber T,. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 1996; 106: 446-453. (Pubitemid 26117582)
8. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 1992; 175: 1353-1365.
9. Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 1992; 175: 1285-1290.
10. Jurgens M, Wollenberg A, Hanau D, Delasalle H, Bieber T,. Activation of human epidermal Langerhans cells by engagement of the high-affinity receptor for ige. Fc-Epsilon-Ri. J Immunol 1995; 155: 5184-5189.
11. Kraft S, Wessendorf JHM, Haberstok J, Novak N, Wollenberg A, Bieber T,. Enhanced expression and activity of protein-tyrosine kinases establishes a functional signaling pathway only in Fc epsilon RIhigh Langerhans cells from atopic individuals. J Investig Dermatol 2002; 119: 804-811. (Pubitemid 35340904)
12. Novak N, Valenta R, Bohle B, Laffer S, Haberstok J, Kraft S, et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 2004; 113: 949-957. (Pubitemid 38608606)
13. Novak N, Bieber T,. 2 Dendritic cells as regulators of immunity and tolerance. J Allergy Clin Immunol 2008; 121 (2 Suppl): S370-S374, quiz S413. (Pubitemid 351172419)
14. Bieber T,. The pro- and anti-inflammatory properties of human antigen-presenting cells expressing the high affinity receptor for IgE (Fc epsilon RI). Immunobiology 2007; 212: 499-503. (Pubitemid 46830354)
15. Boguniewicz M, Leung DY,. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010; 125: 4-13; quiz 14-15.
16. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A,. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012; 25: 106-141.
17. Hertz CJ, Kiertscher SM, Godowski PJ, Bouis DA, Norgard MV, Roth MD, et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001; 166: 2444-2450. (Pubitemid 32173480)
18. Kawai T, Akira S,. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005; 17: 338-344. (Pubitemid 40848534)
19. Allam JP, Klein E, Bieber T, Novak N,. Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J Invest Dermatol 2004; 123: 676-682. (Pubitemid 39281608)
20. Nishiyama C, Hasegawa M, Nishiyama M, Takahashi K, Akizawa Y, Yokota T, et al. Regulation of human Fc epsilon RI alpha-chain gene expression by multiple transcription factors. J Immunol 2002; 168: 4546-4552. (Pubitemid 34441359)
21. Wollenberg A, Wen S, Bieber T,. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995; 346: 1626-1627. (Pubitemid 26001853)
22. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
23. Reginald K, Westritschnig K, Werfel T, Heratizadeh A, Novak N, Focke-Tejkl M, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy 2011; 41: 357-369.
24. Breuer K, Wittmann M, Bosche B, Kapp A, Werfel T,. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000; 55: 551-555. (Pubitemid 30322202)
25. Boguniewicz M, Leung DY,. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
26. Potaczek DP, Nishiyama C, Sanak M, Szczeklik A, Okumura K,. Genetic variability of the high-affinity IgE receptor alpha-subunit (FcepsilonRIalpha). Immunol Res 2009a; 45: 75-84.
27. Potaczek DP, Maeda K, Wang QH, Nakano N, Kanada S, Stepien E, et al. FcepsilonRIalpha gene -18483A>C polymorphism affects transcriptional activity through YY1 binding. Immunogenetics 2009b; 61: 649-655.
28. Liang Y, Wang P, Zhao M, Liang G, Yin H, Zhang G, et al. Demethylation of the FCER1G promoter leads to FcepsilonRI overexpression on monocytes of patients with atopic dermatitis. Allergy 2012; 67: 424-430.
29. Yoshioka M, Fukuishi N, Iriguchi S, Ohsaki K, Yamanobe H, Inukai A, et al. Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 2007; 120: 452-461. (Pubitemid 47102373)
30. Goto T, Soma Y, Ra C, Kawa Y, Kubota Y, Mizoguchi M,. Enhanced expression of the high-affinity receptor for IgE (Fc(epsilon)RI) associated with decreased numbers of Langerhans cells in the lesional epidermis of atopic dermatitis. J Dermatol Sci 2001; 27: 156-161. (Pubitemid 32964687)
31. Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T,. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001; 107: 519-525. (Pubitemid 32210034)
32. Nishiyama C, Ito T, Nishiyama M, Masaki S, Maeda K, Nakano N, et al. GATA-1 is required for expression of Fc{epsilon}RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow. Int Immunol 2005; 17: 847-856. (Pubitemid 41417952)
33. Gobel F, Taschner S, Jurkin J, Konradi S, Vaculik C, Richter S, et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood 2009; 114: 3813-3821.
34. Hasegawa M, Nishiyama C, Nishiyama M, Akizawa Y, Mitsuishi K, Ito T, et al. A novel -66T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J Immunol 2003; 171: 1927-1933. (Pubitemid 36966476)